Study of GL701 in Men With Systemic Lupus Erythematosus

Summary

Lupus flares and other symptoms associated with systemic lupus erythematosus (SLE) may be caused by a deficiency of dehydroepiandrosterone (DHEA). GL701 is an investigational new drug meant to enhance DHEA levels. This study is designed to evaluate both the safety and efficacy of GL701 in male lupus patients.

Timeline

Start

1998-03

Primary completion

—

Completion

—

Drugs

Indications